Surface modification of PLGA particles: The interplay between stabilizer, ligand size, and hydrophobic interactions

Langmuir

Volumn 26, Issue 3, 2010, Pages 1855-1859

  Ratzinger, Gerda ^a   Länger, Ursula ^a   Neutsch, Lukas ^a   Pittner, Fritz ^a   Wirth, Michael ^a   Gabor, Franz ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COUPLING EFFICIENCY; FLUORIMETRIC; FUNCTIONALIZED; HYDROPHOBIC INTERACTIONS; LIGAND COUPLING; OPTIMUM CONCENTRATION; PARTICLE AGGREGATION; PLGA MICROPARTICLES; PLURONIC-F68; PLURONICS; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); SIZE RANGES; STERIC STABILIZERS; SURFACE MODIFICATION; THREE MODELS;

CONCENTRATION (PROCESS); FLOW CYTOMETRY; HYDROPHOBICITY; LIGANDS; ORGANIC POLYMERS; SURFACE TREATMENT;

AGGLOMERATION;

CADAVERINE; FLUORESCEIN; FLUORESCENT DYE; IMMOBILIZED PROTEIN; IMMUNOGLOBULIN G; LIGAND; POLOXAMER; POLYGLACTIN;

ANIMAL; ARTICLE; CHEMISTRY; FLOW CYTOMETRY; HYDROPHOBICITY; SURFACE PROPERTY;

ANIMALS; CADAVERINE; FLOW CYTOMETRY; FLUORESCEIN; FLUORESCENT DYES; HYDROPHOBICITY; IMMOBILIZED PROTEINS; IMMUNOGLOBULIN G; LIGANDS; POLOXAMER; POLYGLACTIN 910; SURFACE PROPERTIES;

EID: 75749149779     PISSN: 07437463     EISSN: None     Source Type: Journal    
DOI: 10.1021/la902602z     Document Type: Article

References (27)

1. Koo, O. M.; Rubinstein, I.; Onyuksel, H. Nanomedicine 2005, 1, 193-212.
2. Brigger, I.; Dubernet, C.; Couvreur, P. Adv. Drug Delivery Rev. 2002, 54, 631-651.
3. Devalapally, H.; Chakilam, A.; Amiji, M. M. J. Pharm. Sci. 2007, 96, 2547-2565.
4. Byrne, J. D.; Betancourt, T.; Brannon-Peppas, L. Adv. Drug Delivery Rev. 2008, 60, 1615-1626.
5. Couvreur, P.; Vauthier, C. Pharm. Res. 2006, 23, 1417-1450.
6. Gabor, F.; Wirth, M. STP Pharma Sci. 2003, 13, 3-16.
7. Gabor, F.; Bogner, E.; Weissenboeck, A.; Wirth, M. Adv. DrugDelivery Rev. 2004, 56, 459-480.
8. Lochner, N.; Pittner, F.; Wirth, M.; Gabor, F. Pharm. Res. 2003, 20, 833-839.
9. Weissenboeck, A.; Wirth, M.; Gabor, F. J. Controlled Release 2004, 99, 383-392.
10. Elnakat, H.; Ratnam, M. Adv. Drug Delivery Rev. 2004, 56, 1067-1084.
11. Mundargi, R. C.; Babu, V. R.; Rangaswamy, V.; Patel, P.; Aminabhavi, T. M. J. Controlled Release 2008, 125, 193-209.
12. Bala, I.; Hariharan, S.; Kumar, M. N. V. R. Crlt. Rev. Ther. Drug Carrier Syst. 2004, 21, 387-422.
13. Wischke, C.; Schwendeman, S. P. Int. J. Pharm. 2008, 364, 298-327.
14. Freitas, S.; Merkle, H. P.; Gander, B. J. Controlled Release 2005, 102, 313-332.
15. Vandervoort, J.; Ludwig, A. Int. J. Pharm. 2002, 238, 77-92.
16. Feczkó, T.; Tóth, J.; Gyenis, J. Colloids Surf., A: Physicochem. Eng. Aspects 2008, 319, 188-195.
17. Li, J.-T.; Caldwell, K. D.; Rapoport, N. Langmuir 1994, 10, 4475-4482.
18. Santander-Ortega, M. J,; Jódar-Reyes, A. B,; Csaba, N.; Bastos-González, D.; Ortega-Vinuesa, J. L. J. Colloid Interface Sci. 2006, 302, 522-529.
19. Weissenboeck, A.; Bogner, E.; Wirth, M.; Gabor, F. Pharm. Res. 2004, 21, 1917-1923.
20. Ertl, B.; Heigl, F.; Wirth, M.; Gabor, F. J. Drug Targeting 2000, 8, 173-184.
21. Scholes, P. D.; Coombes, A. G. A.; Illum, L.; Davis, S. S.; Watts, J. F.; Ustariz, C.; Vert, M.; Davies, M. C. J. Controlled Release 1999, 59, 261-278.
22. Song, K. C.; Lee, H. S.; Choung, I. Y.; Cho, K. I.; Ahn, Y.; Choi, E. J. Colloids Surf., A: Physicochem. Eng. Asp. 2006, 276, 162-167.
23. McCarron, P. A.; Marouf, W. M.; Donnelly, R. F.; Scott, C. J. Biomed. Mater. Res. 2008, 87, 873-884.
24. Ding, A. G.; Schwendeman, S. P. J. Pharm. Sci. 2004, 93, 322-331.
25. Thiele, L.; Diederichs, J. E.; Reszka, R.; Merkle, H. P.; Walter, E. Biomaterials 2003, 24, 1409-1418.
26. Goldstein, I. J.; Poretz, R. D. In The Lectins: Properties, Functions, and Applications in Biology and Medicine; Liener, I. E., Sharon, N., Goldstein I. J., Eds.; Academic Press: Orlando, 1.986.
27. Bozkir, A.; Saka, O. M. Farmaco 2005, 60, 840-846.